NK-1R antagonists bind to NK-1R expressed in tumor cells and block all the favorable effects mediated by SP on tumor cells, such as proliferation and migration, prevention of apoptosis, and the Warburg effect (glycolytic rate increase) and angiogenesis [22]. This evidence concerns the gene TACR1 and neoplasm.